Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Suisse (CSUI) Shares Outstanding (Weighted Average) (2016 - 2025)

Cannabis Suisse (CSUI) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $70.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.0% to $70.7 million in Q4 2025 year-over-year; TTM through Nov 2025 was $70.7 million, a 0.0% change, with the full-year FY2025 number at $70.7 million, up 49.38% from a year prior.
  • Shares Outstanding (Weighted Average) was $70.7 million for Q4 2025 at Cannabis Suisse, roughly flat from $70.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $70.7 million in Q3 2024 to a low of $31.1 million in Q4 2021.
  • A 5-year average of $49.1 million and a median of $44.3 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): fell 9.88% in 2021, then soared 59.71% in 2024.
  • Cannabis Suisse's Shares Outstanding (Weighted Average) stood at $31.1 million in 2021, then soared by 30.76% to $40.7 million in 2022, then grew by 10.79% to $45.0 million in 2023, then soared by 56.92% to $70.7 million in 2024, then changed by 0.0% to $70.7 million in 2025.
  • Per Business Quant, the three most recent readings for CSUI's Shares Outstanding (Weighted Average) are $70.7 million (Q4 2025), $70.7 million (Q3 2025), and $70.7 million (Q2 2025).